958 results on '"Ruprecht Klemens"'
Search Results
52. Microfibrillar-associated protein 4 as a potential marker of acute relapse in inflammatory demyelinating diseases of the central nervous system: Pathological and clinical aspects
53. Increased Serum Neurofilament Light and Thin Ganglion Cell–Inner Plexiform Layer Are Additive Risk Factors for Disease Activity in Early Multiple Sclerosis
54. Comparison of probabilistic tractography and tract-based spatial statistics for assessing optic radiation damage in patients with autoimmune inflammatory disorders of the central nervous system
55. Serum Neurofilament Light Chain in COVID-19 and the Influence of Renal Function
56. Serum tau protein elevation in migraine: a cross-sectional case- control study
57. Synapsin-antibodies in psychiatric and neurological disorders: Prevalence and clinical findings
58. Alzheimer's disease: Elevated pigment epithelium-derived factor in the cerebrospinal fluid is mostly of systemic origin
59. Severe structural and functional visual system damage leads to profound loss of vision-related quality of life in patients with neuromyelitis optica spectrum disorders
60. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
61. Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica
62. Correction: Autoantibodies to synapsin I sequestrate synapsin I and alter synaptic function
63. Interactions of optic radiation lesions with retinal and brain atrophy in early multiple sclerosis.
64. Author response: Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis
65. Analysis of soluble interleukin-2 receptor as CSF biomarker for neurosarcoidosis
66. Cortical topological network changes following optic neuritis
67. Quantitative 7T MRI does not detect occult brain damage in neuromyelitis optica
68. Low intrathecal antibody production despite high seroprevalence of Epstein–Barr virus in multiple sclerosis: a review of the literature
69. Hypertrophic Pachymeningitis with Persistent Intrathecal Inflammation Secondary to Neurosarcoidosis Treated with Intraventricular Chemotherapy: A Case Report
70. Immunomodulatory Effects of New Phenanthrene Derivatives from Dendrobium crumenatum
71. Real-world data on eculizumab treatment in NMOSD: high efficacy and potential challenges (P13-5.017)
72. Microfibrillar-associated Protein 4 as Potential Marker of Acute Relapse in Inflammatory Demyelinating Diseases of the Central Nervous System: Pathological and Clinical Aspects
73. Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: A peptide microarray-based case-control study
74. Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein–Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis
75. Validating Alzheimer's disease micro RNAs using next-generation sequencing
76. Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions
77. Racial differences in neuromyelitis optica spectrum disorder
78. Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis
79. Multi-parameter immune profiling of peripheral blood mononuclear cells by multiplexed single-cell mass cytometry in patients with early multiple sclerosis
80. Autoantibodies to synapsin I sequestrate synapsin I and alter synaptic function
81. Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study
82. The spectrum of central nervous system involvement in Whipple's disease.
83. Humoral immune responses remain quantitatively impaired but improve qualitatively in anti-CD20-treated patients with multiple sclerosis after three or four COVID-19 vaccinations
84. CD4+T cell mitochondrial genotype in Multiple Sclerosis: a cross-sectional and longitudinal analysis
85. Retinal ganglion cell loss is associated with future disability worsening in early relapsing–remitting multiple sclerosis
86. Analysing cerebrospinal fluid with explainable deep learning: From diagnostics to insights
87. 1,2-13C2-Glucose Tracing Approach to Assess Metabolic Alterations of Human Monocytes under Neuroinflammatory Conditions
88. Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort
89. Association of serum Epstein–Barr nuclear antigen-1 antibodies and intrathecal immunoglobulin synthesis in early multiple sclerosis
90. sj-docx-1-msj-10.1177_13524585231161253 – Supplemental material for Humoral immune responses remain quantitatively impaired but improve qualitatively in anti-CD20-treated patients with multiple sclerosis after three or four COVID-19 vaccinations
91. Hypertrophic Pachymeningitis with Persistent Intrathecal Inflammation Secondary to Neurosarcoidosis Treated with Intraventricular Chemotherapy: A Case Report
92. Multifrequency magnetic resonance elastography of the brain reveals tissue degeneration in neuromyelitis optica spectrum disorder
93. Glial fibrillary acidic protein as a biomarker in neuromyelitis optica spectrum disorder: a current review
94. Multiple sclerosis: The elevated antibody response to Epstein–Barr virus primarily targets, but is not confined to, the glycine–alanine repeat of Epstein–Barr nuclear antigen-1
95. Association of Visual Impairment in Neuromyelitis Optica Spectrum Disorder With Visual Network Reorganization
96. Anatomical Wiring and Functional Networking Changes in the Visual System Following Optic Neuritis
97. Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German–Austrian retrospective multicenter study in patients with a clinically isolated syndrome
98. Neuromyelitis optica does not impact periventricular venous density versus healthy controls: a 7.0 Tesla MRI clinical study
99. Humoral immune responses remain quantitatively impaired but improve qualitatively in anti-CD20 treated patients with multiple sclerosis after three or four COVID-19 vaccinations
100. The spectrum of central nervous system involvement in Whipple's disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.